Review



ffpe lung  (OriGene)


Bioz Verified Symbol OriGene is a verified supplier
Bioz Manufacturer Symbol OriGene manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 91

    Structured Review

    OriGene ffpe lung
    Fig. 1 | Decreased REV-ERBα protein abundance and increased protein levels of COL1A1 and LOX <t>in</t> <t>IPF</t> lungs compared to healthy control. Healthy control and IPF formalin fixed-paraffin embedded <t>(FFPE)</t> lung samples were purchased from Origene Inc. Healthy controls contained 100% normal lung architecture with 85% alveoli surface area. IPF patient samples contained at least 50% lesion surface area. The protein abundance of REV-ERBα, COL1A1, and LOX were visualized and
    Ffpe Lung, supplied by OriGene, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pm36894533-48-48-54?v=OriGene
    Average 91 stars, based on 1 article reviews
    ffpe lung - by Bioz Stars, 2026-08
    91/100 stars

    Images

    1) Product Images from "Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization."

    Article Title: Circadian clock molecule REV-ERBα regulates lung fibrotic progression through collagen stabilization.

    Journal: Nature communications

    doi: 10.1038/s41467-023-36896-0

    Fig. 1 | Decreased REV-ERBα protein abundance and increased protein levels of COL1A1 and LOX in IPF lungs compared to healthy control. Healthy control and IPF formalin fixed-paraffin embedded (FFPE) lung samples were purchased from Origene Inc. Healthy controls contained 100% normal lung architecture with 85% alveoli surface area. IPF patient samples contained at least 50% lesion surface area. The protein abundance of REV-ERBα, COL1A1, and LOX were visualized and
    Figure Legend Snippet: Fig. 1 | Decreased REV-ERBα protein abundance and increased protein levels of COL1A1 and LOX in IPF lungs compared to healthy control. Healthy control and IPF formalin fixed-paraffin embedded (FFPE) lung samples were purchased from Origene Inc. Healthy controls contained 100% normal lung architecture with 85% alveoli surface area. IPF patient samples contained at least 50% lesion surface area. The protein abundance of REV-ERBα, COL1A1, and LOX were visualized and

    Techniques Used: Quantitative Proteomics, Control

    Fig. 7 | IAV infection induced dysregulation of profibrotic progression exa- cerbated in Rev-erbα Het mice. WT and Rev-erbα Het mice (equal number of male and female) infected (103 PFU/mouse) with IAV for 15 days, and lungs were sepa- rated for RNA/protein isolation, or fixed with 10% formalin for FFPE sections. a The protein abundance of COL1A2, VIM and activated LOX were measured by western blot. Representative blot images were shown. Different targets were run on the same membrane: COL1A2, VIM and activated LOX were probed in the same membrane and β-ACTIN was used as an endogenous control (n = 5–6 mice per group). b The localizations of COL1A1 and LOX were determined by
    Figure Legend Snippet: Fig. 7 | IAV infection induced dysregulation of profibrotic progression exa- cerbated in Rev-erbα Het mice. WT and Rev-erbα Het mice (equal number of male and female) infected (103 PFU/mouse) with IAV for 15 days, and lungs were sepa- rated for RNA/protein isolation, or fixed with 10% formalin for FFPE sections. a The protein abundance of COL1A2, VIM and activated LOX were measured by western blot. Representative blot images were shown. Different targets were run on the same membrane: COL1A2, VIM and activated LOX were probed in the same membrane and β-ACTIN was used as an endogenous control (n = 5–6 mice per group). b The localizations of COL1A1 and LOX were determined by

    Techniques Used: Infection, Isolation, Quantitative Proteomics, Western Blot, Membrane, Control



    Similar Products

    94
    Proteintech tissue sections
    Tissue Sections, supplied by Proteintech, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pmc12999324-137-0-11?v=Proteintech
    Average 94 stars, based on 1 article reviews
    tissue sections - by Bioz Stars, 2026-08
    94/100 stars
      Buy from Supplier

    86
    Servicebio Inc tissue sections
    Tissue Sections, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pm42284447-351-1-11?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    tissue sections - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Nature Biotechnology ht29 lung metastatic colonization model tissue sections
    Ht29 Lung Metastatic Colonization Model Tissue Sections, supplied by Nature Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pm42277225-545-14-0?v=Nature+Biotechnology
    Average 86 stars, based on 1 article reviews
    ht29 lung metastatic colonization model tissue sections - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Jackson Laboratory brain tissue sections
    Brain Tissue Sections, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pm42251444-120-9-23?v=Jackson+Laboratory
    Average 86 stars, based on 1 article reviews
    brain tissue sections - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    Servicebio Inc tissue sectioning
    Tissue Sectioning, supplied by Servicebio Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pm42249374-167-3-11?v=Servicebio+Inc
    Average 86 stars, based on 1 article reviews
    tissue sectioning - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    10X Genomics xenium5k tissue sections
    A . Workflow for predicting spatial gene-expression programs directly from histology images using SQUALL. B . Benchmarking of virtual biomarker prediction on internal and external <t>Xenium5K</t> sections. SQUALL was benchmarked against ST-Net, iSTAR, EGN, EGNv2, and Path2Space on three Xenium5K sections. Performance was evaluated using Pearson correlation on ( Left ) per tissue sections and ( Right ) overall correlations. HCC: hepatocellular carcinoma; OC: ovarian carcinoma; CC: cervical carcinoma. Box plots: center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; statistical test: two-sided Mann-Whitney U test. C . Pairwise scatterplots comparing per-gene Pearson correlations between SQUALL (x-axis, one panel per method) and each of six competing methods. D . Bar plot showing reverse ranking results of prediction performance across biomarker subsets. Prediction performance was inverse ranked within each section by average Pearson correlation, with higher rank indicates better performance. E . Representative virtual biomarker predictions. Left to right: original histology images (20× magnification) and virtually profiled expression of selected genes from all competing methods and SQUALL. Rows show ground truth and predictions for MET (HCC, internal), IFGR1 (OC, internal), and STAT1 (CC, external). Scale bar, 1 mm. F . Schematic of SQUALL applied to virtual biomarker profiling directly using cohort-level histology whole-slides images. G . Bar plot showing GSEA results based on SQUALL-virtually profiled bulk gene expression in the TCGA-LIHC cohort. Genes were ranked by coefficients from a multivariable Cox regression model adjusted for age and stage. Pathways with NES > 0 are associated with poorer prognosis, whereas pathways with NES < 0 are associated with better prognosis. NES, normalized enrichment score. H . Spatial plot of representative annotated tumor regions from Chiara et al. Scale bar, 1 mm. I . Ranking plot of hazard ratios for SQUALL-virtually profiled gene expression within tumor regions of the TCGA-CESC cohort. Hazard ratios were estimated using multivariable Cox proportional hazards models adjusted for age and stage. Representative genes are shown, including DNA double-strand break response (blue), DNA repair (orange), innate immune/complement regulation (green), and adaptive immune response (violet) genes. Solid dots indicate genes with FDR < 0.1. J . Ridge plot of gene set enrichment analysis based on SQUALL virtually profiled tumor region biomarkers on TCGA-CESC cohort. NES, normalized enrichment score. K . Hazard ratios for clinical variables and SQUALL-predicted CD8 + T cell signatures in the TCGA-CESC cohort, estimated using univariate Cox proportional hazards models. Dots indicate hazard ratios and bars indicate 95% confidence interval. Statistical significance was assessed using a one-sided Wald test. L . Representative examples of predicted CD8 + T cell infiltration in the TCGA-CESC cohort. Long-term survivor with predicted intertumoral CD8 + T cells (red dashed area) ( Left ). Short-term survivor with CD8 + cells mainly at the tumor margin ( Right ). Scale bar, 5 mm. Statistical significance: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; n.s., not significant.
    Xenium5k Tissue Sections, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/bio_rxiv__64898__2026__06__01__729028-443-1-24?v=10X+Genomics
    Average 86 stars, based on 1 article reviews
    xenium5k tissue sections - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    86
    10X Genomics visium tissue section test slides
    A . Workflow for predicting spatial gene-expression programs directly from histology images using SQUALL. B . Benchmarking of virtual biomarker prediction on internal and external <t>Xenium5K</t> sections. SQUALL was benchmarked against ST-Net, iSTAR, EGN, EGNv2, and Path2Space on three Xenium5K sections. Performance was evaluated using Pearson correlation on ( Left ) per tissue sections and ( Right ) overall correlations. HCC: hepatocellular carcinoma; OC: ovarian carcinoma; CC: cervical carcinoma. Box plots: center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; statistical test: two-sided Mann-Whitney U test. C . Pairwise scatterplots comparing per-gene Pearson correlations between SQUALL (x-axis, one panel per method) and each of six competing methods. D . Bar plot showing reverse ranking results of prediction performance across biomarker subsets. Prediction performance was inverse ranked within each section by average Pearson correlation, with higher rank indicates better performance. E . Representative virtual biomarker predictions. Left to right: original histology images (20× magnification) and virtually profiled expression of selected genes from all competing methods and SQUALL. Rows show ground truth and predictions for MET (HCC, internal), IFGR1 (OC, internal), and STAT1 (CC, external). Scale bar, 1 mm. F . Schematic of SQUALL applied to virtual biomarker profiling directly using cohort-level histology whole-slides images. G . Bar plot showing GSEA results based on SQUALL-virtually profiled bulk gene expression in the TCGA-LIHC cohort. Genes were ranked by coefficients from a multivariable Cox regression model adjusted for age and stage. Pathways with NES > 0 are associated with poorer prognosis, whereas pathways with NES < 0 are associated with better prognosis. NES, normalized enrichment score. H . Spatial plot of representative annotated tumor regions from Chiara et al. Scale bar, 1 mm. I . Ranking plot of hazard ratios for SQUALL-virtually profiled gene expression within tumor regions of the TCGA-CESC cohort. Hazard ratios were estimated using multivariable Cox proportional hazards models adjusted for age and stage. Representative genes are shown, including DNA double-strand break response (blue), DNA repair (orange), innate immune/complement regulation (green), and adaptive immune response (violet) genes. Solid dots indicate genes with FDR < 0.1. J . Ridge plot of gene set enrichment analysis based on SQUALL virtually profiled tumor region biomarkers on TCGA-CESC cohort. NES, normalized enrichment score. K . Hazard ratios for clinical variables and SQUALL-predicted CD8 + T cell signatures in the TCGA-CESC cohort, estimated using univariate Cox proportional hazards models. Dots indicate hazard ratios and bars indicate 95% confidence interval. Statistical significance was assessed using a one-sided Wald test. L . Representative examples of predicted CD8 + T cell infiltration in the TCGA-CESC cohort. Long-term survivor with predicted intertumoral CD8 + T cells (red dashed area) ( Left ). Short-term survivor with CD8 + cells mainly at the tumor margin ( Right ). Scale bar, 5 mm. Statistical significance: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; n.s., not significant.
    Visium Tissue Section Test Slides, supplied by 10X Genomics, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pmc13156600-324-4-13?v=10X+Genomics
    Average 86 stars, based on 1 article reviews
    visium tissue section test slides - by Bioz Stars, 2026-08
    86/100 stars
      Buy from Supplier

    99
    Qiagen tissue sections
    A . Workflow for predicting spatial gene-expression programs directly from histology images using SQUALL. B . Benchmarking of virtual biomarker prediction on internal and external <t>Xenium5K</t> sections. SQUALL was benchmarked against ST-Net, iSTAR, EGN, EGNv2, and Path2Space on three Xenium5K sections. Performance was evaluated using Pearson correlation on ( Left ) per tissue sections and ( Right ) overall correlations. HCC: hepatocellular carcinoma; OC: ovarian carcinoma; CC: cervical carcinoma. Box plots: center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; statistical test: two-sided Mann-Whitney U test. C . Pairwise scatterplots comparing per-gene Pearson correlations between SQUALL (x-axis, one panel per method) and each of six competing methods. D . Bar plot showing reverse ranking results of prediction performance across biomarker subsets. Prediction performance was inverse ranked within each section by average Pearson correlation, with higher rank indicates better performance. E . Representative virtual biomarker predictions. Left to right: original histology images (20× magnification) and virtually profiled expression of selected genes from all competing methods and SQUALL. Rows show ground truth and predictions for MET (HCC, internal), IFGR1 (OC, internal), and STAT1 (CC, external). Scale bar, 1 mm. F . Schematic of SQUALL applied to virtual biomarker profiling directly using cohort-level histology whole-slides images. G . Bar plot showing GSEA results based on SQUALL-virtually profiled bulk gene expression in the TCGA-LIHC cohort. Genes were ranked by coefficients from a multivariable Cox regression model adjusted for age and stage. Pathways with NES > 0 are associated with poorer prognosis, whereas pathways with NES < 0 are associated with better prognosis. NES, normalized enrichment score. H . Spatial plot of representative annotated tumor regions from Chiara et al. Scale bar, 1 mm. I . Ranking plot of hazard ratios for SQUALL-virtually profiled gene expression within tumor regions of the TCGA-CESC cohort. Hazard ratios were estimated using multivariable Cox proportional hazards models adjusted for age and stage. Representative genes are shown, including DNA double-strand break response (blue), DNA repair (orange), innate immune/complement regulation (green), and adaptive immune response (violet) genes. Solid dots indicate genes with FDR < 0.1. J . Ridge plot of gene set enrichment analysis based on SQUALL virtually profiled tumor region biomarkers on TCGA-CESC cohort. NES, normalized enrichment score. K . Hazard ratios for clinical variables and SQUALL-predicted CD8 + T cell signatures in the TCGA-CESC cohort, estimated using univariate Cox proportional hazards models. Dots indicate hazard ratios and bars indicate 95% confidence interval. Statistical significance was assessed using a one-sided Wald test. L . Representative examples of predicted CD8 + T cell infiltration in the TCGA-CESC cohort. Long-term survivor with predicted intertumoral CD8 + T cells (red dashed area) ( Left ). Short-term survivor with CD8 + cells mainly at the tumor margin ( Right ). Scale bar, 5 mm. Statistical significance: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; n.s., not significant.
    Tissue Sections, supplied by Qiagen, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/tissue+sectioning/pmc13160414-83-4-12?v=Qiagen
    Average 99 stars, based on 1 article reviews
    tissue sections - by Bioz Stars, 2026-08
    99/100 stars
      Buy from Supplier

    Image Search Results


    A . Workflow for predicting spatial gene-expression programs directly from histology images using SQUALL. B . Benchmarking of virtual biomarker prediction on internal and external Xenium5K sections. SQUALL was benchmarked against ST-Net, iSTAR, EGN, EGNv2, and Path2Space on three Xenium5K sections. Performance was evaluated using Pearson correlation on ( Left ) per tissue sections and ( Right ) overall correlations. HCC: hepatocellular carcinoma; OC: ovarian carcinoma; CC: cervical carcinoma. Box plots: center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; statistical test: two-sided Mann-Whitney U test. C . Pairwise scatterplots comparing per-gene Pearson correlations between SQUALL (x-axis, one panel per method) and each of six competing methods. D . Bar plot showing reverse ranking results of prediction performance across biomarker subsets. Prediction performance was inverse ranked within each section by average Pearson correlation, with higher rank indicates better performance. E . Representative virtual biomarker predictions. Left to right: original histology images (20× magnification) and virtually profiled expression of selected genes from all competing methods and SQUALL. Rows show ground truth and predictions for MET (HCC, internal), IFGR1 (OC, internal), and STAT1 (CC, external). Scale bar, 1 mm. F . Schematic of SQUALL applied to virtual biomarker profiling directly using cohort-level histology whole-slides images. G . Bar plot showing GSEA results based on SQUALL-virtually profiled bulk gene expression in the TCGA-LIHC cohort. Genes were ranked by coefficients from a multivariable Cox regression model adjusted for age and stage. Pathways with NES > 0 are associated with poorer prognosis, whereas pathways with NES < 0 are associated with better prognosis. NES, normalized enrichment score. H . Spatial plot of representative annotated tumor regions from Chiara et al. Scale bar, 1 mm. I . Ranking plot of hazard ratios for SQUALL-virtually profiled gene expression within tumor regions of the TCGA-CESC cohort. Hazard ratios were estimated using multivariable Cox proportional hazards models adjusted for age and stage. Representative genes are shown, including DNA double-strand break response (blue), DNA repair (orange), innate immune/complement regulation (green), and adaptive immune response (violet) genes. Solid dots indicate genes with FDR < 0.1. J . Ridge plot of gene set enrichment analysis based on SQUALL virtually profiled tumor region biomarkers on TCGA-CESC cohort. NES, normalized enrichment score. K . Hazard ratios for clinical variables and SQUALL-predicted CD8 + T cell signatures in the TCGA-CESC cohort, estimated using univariate Cox proportional hazards models. Dots indicate hazard ratios and bars indicate 95% confidence interval. Statistical significance was assessed using a one-sided Wald test. L . Representative examples of predicted CD8 + T cell infiltration in the TCGA-CESC cohort. Long-term survivor with predicted intertumoral CD8 + T cells (red dashed area) ( Left ). Short-term survivor with CD8 + cells mainly at the tumor margin ( Right ). Scale bar, 5 mm. Statistical significance: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; n.s., not significant.

    Journal: bioRxiv

    Article Title: Integrating Histology with Spatial Molecular Programs Using a Multimodal Foundation Model

    doi: 10.64898/2026.06.01.729028

    Figure Lengend Snippet: A . Workflow for predicting spatial gene-expression programs directly from histology images using SQUALL. B . Benchmarking of virtual biomarker prediction on internal and external Xenium5K sections. SQUALL was benchmarked against ST-Net, iSTAR, EGN, EGNv2, and Path2Space on three Xenium5K sections. Performance was evaluated using Pearson correlation on ( Left ) per tissue sections and ( Right ) overall correlations. HCC: hepatocellular carcinoma; OC: ovarian carcinoma; CC: cervical carcinoma. Box plots: center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; statistical test: two-sided Mann-Whitney U test. C . Pairwise scatterplots comparing per-gene Pearson correlations between SQUALL (x-axis, one panel per method) and each of six competing methods. D . Bar plot showing reverse ranking results of prediction performance across biomarker subsets. Prediction performance was inverse ranked within each section by average Pearson correlation, with higher rank indicates better performance. E . Representative virtual biomarker predictions. Left to right: original histology images (20× magnification) and virtually profiled expression of selected genes from all competing methods and SQUALL. Rows show ground truth and predictions for MET (HCC, internal), IFGR1 (OC, internal), and STAT1 (CC, external). Scale bar, 1 mm. F . Schematic of SQUALL applied to virtual biomarker profiling directly using cohort-level histology whole-slides images. G . Bar plot showing GSEA results based on SQUALL-virtually profiled bulk gene expression in the TCGA-LIHC cohort. Genes were ranked by coefficients from a multivariable Cox regression model adjusted for age and stage. Pathways with NES > 0 are associated with poorer prognosis, whereas pathways with NES < 0 are associated with better prognosis. NES, normalized enrichment score. H . Spatial plot of representative annotated tumor regions from Chiara et al. Scale bar, 1 mm. I . Ranking plot of hazard ratios for SQUALL-virtually profiled gene expression within tumor regions of the TCGA-CESC cohort. Hazard ratios were estimated using multivariable Cox proportional hazards models adjusted for age and stage. Representative genes are shown, including DNA double-strand break response (blue), DNA repair (orange), innate immune/complement regulation (green), and adaptive immune response (violet) genes. Solid dots indicate genes with FDR < 0.1. J . Ridge plot of gene set enrichment analysis based on SQUALL virtually profiled tumor region biomarkers on TCGA-CESC cohort. NES, normalized enrichment score. K . Hazard ratios for clinical variables and SQUALL-predicted CD8 + T cell signatures in the TCGA-CESC cohort, estimated using univariate Cox proportional hazards models. Dots indicate hazard ratios and bars indicate 95% confidence interval. Statistical significance was assessed using a one-sided Wald test. L . Representative examples of predicted CD8 + T cell infiltration in the TCGA-CESC cohort. Long-term survivor with predicted intertumoral CD8 + T cells (red dashed area) ( Left ). Short-term survivor with CD8 + cells mainly at the tumor margin ( Right ). Scale bar, 5 mm. Statistical significance: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; n.s., not significant.

    Article Snippet: Three Xenium5K tissue sections were used for benchmarking ( Table S31 ): one from the SPATCH cohort (hepatocellular carcinoma) and two public datasets from 10x Genomics (ovarian cancer: https://www.10xgenomics.com/cn/datasets/xenium-prime-ffpe-human-ovarian-cancer ; cervical cancer: https://www.10xgenomics.com/cn/datasets/xenium-prime-ffpe-human-cervical-cancer ).

    Techniques: Gene Expression, Biomarker Discovery, MANN-WHITNEY, Expressing

    A-C . Quantitative comparison of SQUALL to iSTAR, ST-Net, EGN, Hist2ST, DeepPT, and Path2Space for virtual biomarker profiling using three Xenium5K sections. Pairwise scatterplots comparing per-gene Pearson correlations between SQUALL (x-axis, one panel per method) and each of six competing methods on one internal hepatocellular carcinoma section ( A ), one external ovarian carcinoma section ( B ), and one external cervical carcinoma section ( C ). D-E . Box plots showing predicted biomarkers expression. Cervical cancer-related differential genes and transcription factors ( D ). T cell, CD4 + T cell, and CD8 + T cell signatures ( E, Left ). CD8 + T effector and exhaustion cell signatures ( E, Right ). Expression was normalized and ranked per tile within tissue section; higher ranks indicate higher predicted expression levels. F . Box plots comparing SQUALL-predicted T cell-related biomarker signature expression between tumor and non-tumor regions. Box plots ( D-F ): center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; statistical test: two-sided Mann-Whitney U test. Statistical significance: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; n.s., not significant.

    Journal: bioRxiv

    Article Title: Integrating Histology with Spatial Molecular Programs Using a Multimodal Foundation Model

    doi: 10.64898/2026.06.01.729028

    Figure Lengend Snippet: A-C . Quantitative comparison of SQUALL to iSTAR, ST-Net, EGN, Hist2ST, DeepPT, and Path2Space for virtual biomarker profiling using three Xenium5K sections. Pairwise scatterplots comparing per-gene Pearson correlations between SQUALL (x-axis, one panel per method) and each of six competing methods on one internal hepatocellular carcinoma section ( A ), one external ovarian carcinoma section ( B ), and one external cervical carcinoma section ( C ). D-E . Box plots showing predicted biomarkers expression. Cervical cancer-related differential genes and transcription factors ( D ). T cell, CD4 + T cell, and CD8 + T cell signatures ( E, Left ). CD8 + T effector and exhaustion cell signatures ( E, Right ). Expression was normalized and ranked per tile within tissue section; higher ranks indicate higher predicted expression levels. F . Box plots comparing SQUALL-predicted T cell-related biomarker signature expression between tumor and non-tumor regions. Box plots ( D-F ): center line, median; box limits, upper and lower quartiles; whiskers, 1.5× interquartile range; statistical test: two-sided Mann-Whitney U test. Statistical significance: * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; n.s., not significant.

    Article Snippet: Three Xenium5K tissue sections were used for benchmarking ( Table S31 ): one from the SPATCH cohort (hepatocellular carcinoma) and two public datasets from 10x Genomics (ovarian cancer: https://www.10xgenomics.com/cn/datasets/xenium-prime-ffpe-human-ovarian-cancer ; cervical cancer: https://www.10xgenomics.com/cn/datasets/xenium-prime-ffpe-human-cervical-cancer ).

    Techniques: Comparison, Biomarker Discovery, Expressing, MANN-WHITNEY